Welcome to BioMed Central's Cancer Gateway, highlighting the latest articles we have published in this field. Content is continually updated, so please bookmark this page and ensure you check it regularly.
Nanoparticles which combine magnetic hyperthermia and anti-cancer drug delivery show potential as a new treatment to target and kill breast cancer cells.
Carol Fabian et al. review early investigations into the use of omega-3 supplementation to prevent breast cancer and to improve outcomes following breast cancer diagnosis.
Adipose cells in the tumour microenvironment may be contributing to resistance to Trastuzumab, a targeted treatment for HER2+ breast cancer.
Moyano and Stefani review key evidence for the role of piRNAs and PIWI in cancers deriving from both germline cells and somatic tissues, and how we can discriminate between a ‘passenger’ vs. a ‘driver’ role in the pathogenesis of these diseases.
Long non-coding RNA profiles were found to predict risk of metastases in lymph node-negative breast cancer patients, and hence may be a source of prognostic information used to combat overtreatment.
Humphrey and Kasinski report on recently developed CRISPR-Cas platforms for global genome editing and address the therapeutic potential of CRISPR-Cas technology for genome-wide functional studies of disease processes, as well as applications beyond genome editing.
The levels of four urinary miRNAs that are specifically altered in breast cancer patients compared to healthy controls may serve as potential non-invasive innovative biomarkers to detect primary breast cancer.
Sanchez-Mejias and Tay review recent discoveries that implicate competing endogenous RNAs (ceRNAs), or natural miRNA sponges, in human cancer. The authors explain how identifying ceRNA regulatory networks can aid the development of new approaches to cancer diagnostics and oligonucleotide-based therapeutics.
Authors of BioMed Central cancer-related articles, by location
Powered by AuthorMapper.com
Cancer and obesity series
We are pleased to invite you to submit your manuscript to a new cross-journal thematic series, Cancer and Obesity. BioMed Central is launching this series in response to the call for increased education, research and advocacy to reduce the toll of obesity as a leading cause of cancer, and a complication in the care of cancer patients.
This collection will explore the biological, translational and clinical links between obesity of and cancer, including the molecular, genetic and hormonal causes of obesity-linked cancers, the impact of behavior change on cancer outcomes, and the impact of obesity on the diagnosis and treatment of cancer.
The following journals will be accepting submissions:
- BMC Cancer
- Cancer & Metabolism
- Clinical Epigenetics
- Gynecologic Oncology Research and Practice
- Journal of Hematology & Oncology
- Journal of Translational Medicine
Please submit your article via the online submission system and indicate in your cover letter that you would like your article to be considered for the Cancer and Obesity series.
For further information please contact: firstname.lastname@example.org.
Cancer news from around the web
- 26 May 2015
- Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies
- 26 May 2015
- How DNA is organized in our cells